用户名: 密码: 验证码:
Calpastatin modulates APP processing in the brains of -amyloid depositing but not wild-type mice
详细信息查看全文 | 推荐本文 |
摘要
We report that neuronal overexpression of the endogenous inhibitor of calpains, calpastatin (CAST), in a mouse model of human Alzheimer's disease (AD) -amyloidosis, the APP23 mouse, reduces -amyloid (A) pathology and A levels when comparing aged, double transgenic (tg) APP23/CAST with APP23 mice. Concurrent with A plaque deposition, aged APP23/CAST mice show a decrease in the steady-state brain levels of the amyloid precursor protein (APP) and APP C-terminal fragments (CTFs) when compared with APP23 mice. This CAST-dependent decrease in APP metabolite levels was not observed in single tg CAST mice expressing endogenous APP or in younger, A plaque predepositing APP23/CAST mice. We also determined that the CAST-mediated inhibition of calpain activity in the brain is greater in the CAST mice with A pathology than in non-APP tg mice, as demonstrated by a decrease in calpain-mediated cytoskeleton protein cleavage. Moreover, aged APP23/CAST mice have reduced extracellular signal-regulated kinase 1/2 (ERK1/2) activity and tau phosphorylation when compared with APP23 mice. In summary, in vivo calpain inhibition mediated by CAST transgene expression reduces A pathology in APP23 mice, with our findings further suggesting that APP metabolism is modified by CAST overexpression as the mice develop A pathology. Our results indicate that the calpain system in neurons is more responsive to CAST inhibition under conditions of A pathology, suggesting that in the disease state neurons may be more sensitive to the therapeutic use of calpain inhibitors.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700